重症患者抗生素治疗:欧洲麻醉学会重症医学科学小组专家意见
该专家意见来自欧洲麻醉学会重症医学科学小组2016年伦敦Euro Anaesthesia会议专家组,总结重症患者抗生素治疗的核心原则。强调抗菌治疗是感染治疗基石,重症患者抗生素选择具有挑战性;临床医生常更关注患者个体而非微生物生态平衡与耐药模式;抗生素过度治疗常见,但基于知情决策的抗生素治疗不一定损害患者结局。
要点
- 抗菌治疗是感染治疗的基石,但重症患者抗生素选择具有挑战性。
- 临床医生对个体患者的责任通常优先于维持微生物生态平衡与耐药模式。
- 抗生素过度治疗常见,但当抗生素治疗由知情决策驱动时,患者结局不一定受损。
核心结论
- 抗菌治疗是感染治疗的基石,重症患者抗生素选择具有挑战性。
- 抗生素过度治疗常见,但当抗生素治疗由知情决策驱动时,患者结局不一定受损。
研究设计与样本
- 2016年Euro Anaesthesia会议(英国伦敦)期间,欧洲麻醉学会重症医学科学小组召集抗生素治疗专家组。
- 本文总结专家组主要结论,即所有参与重症患者治疗的医生必须了解的抗生素治疗原则。
主要发现
- 临床医生在治疗重症患者时,通常对患者的责任感大于对维持常见微生物威胁及其耐药模式的微妙生态平衡的责任感。
- 抗生素过度治疗是常见现象。
临床怎么用
- 重症患者抗生素治疗应基于知情决策,而非仅关注维持微生物生态平衡与耐药模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobial treatment is the cornerstone of infection treatment, and the selection of appropriate antibiotic treatment for critically ill patients is challenging. Clinicians working with critically ill patients usually feel a greater obligation towards their patient than towards maintenance of the delicate ecological balance of prevalent microbiological threats and their resistance patterns. Although antibiotic overtreatment is a frequent phenomenon, patient outcomes need not be compromised when antibiotic treatment is driven by informed decision-making.At the 2016 Euro Anaesthesia Conference (London, UK), the European Society of Anaesthesia Intensive Care Scientific Subcommittee convened an expert panel on antibiotic therapy. This article summarises the main conclusions of the panel, namely the principles of antibiotic therapy that all physicians working with critically ill patients must know.
引用
- Martin-Loeches I, Leone M, Madách K, et al. Antibiotic therapy in the critically ill - expert opinion of the Intensive Care Medicine Scientific Subcommittee of the European Society of Anaesthesiology. Eur J Anaesthesiol. 2017. PMID: 28248705. doi:10.1097/EJA.0000000000000595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。